SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Arcolab’s arm receives USFDA nod for Vinorelbine Injection

03 Sep 2012 Evaluate

Strides Arcolab’s wholly owned subsidiary Onco Therapies, has received US Food and Drug Administration (USFDA) final approval for Abbreviated New Drug Application (ANDA) for Vinorelbine Injection USP, 10 mg/mL packaged in 10 mg/1 mL and 50 mg / 5mL single-dose vials.

Vinorelbine is part of the Oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch. Vinorelbine is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cancer cell growth.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

1070.90 69.10 (6.90%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×